Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin

NCT01335529 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

69

Enrollment

OTHER_GOV

Sponsor class

Conditions

HCV Coinfection
HIV-1 Infection

Interventions

DRUG: Boceprevir, Peg-interferon alfa 2b and Ribavirin

Sponsor

ANRS, Emerging Infectious Diseases

Collaborators

[object Object]
[object Object]